Bristol Myers Squib, Wallingford, Connecticut, United States
AstraZeneca Neuroscience – Cambridge, Massachusetts, United States
University of Washington, Department of Global Health - Seattle, Washington, United States
- Jaisri R. Lingappa, M.D., Ph.D. (Retroviridae - HIV / Cell biology of viral capsid assembly)
- Wes Van Voorhis, M.D., Ph.D. (Parasitology)
Centers for Disease Control and Prevention - Atlanta, Georgia, United States
- Xianfu Wu, Ph.D. (Rhabdoviridae - RABV)
Columbia University - New York, New York, United States
- W. Ian Lipkin, M.D. (Flavoviridae - DENV / Paramyxoviridae - NIPV / Rhabdoviridae - RABV)
Heinrich Heine University of Düsseldorf Medical School - Düsseldorf, Germany
- Carsten Korth, MD, Ph.D.
US Army Medical Research Institute of Infection Diseases* - Fort Detrick, Maryland, United States
- Pam Glass, Ph.D.
- Sina Bavari, Ph.D.
Program for Appropriate Technology in Health, PATH - Seattle, Washington, United States
*The views, opinions, and findings contained herein are those of the authors and should not be construed as an official Department of the Army position, policy, or decision unless so designated by other documentation. Research was conducted in compliance with the Animal Welfare Act and other federal statutes and regulations relating to animals and experiments involving animals and adheres to principles stated in the Guide for the Care and Use of Laboratory Animals, National Research Council, 1996. The facility where this research was conducted is fully accredited by the Association for the Assessment and Accreditation of Laboratory Animal Care International.